SO
SONVY.US Sonova Holding AG
- Market cap
- USD 20.2B
- P/E
- 26.9x
- P/B
- 6.14x
- ROE
- 36.5%
- Dividend yield
- 1.69%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.
Is SONVY.US undervalued?
Graham numberSONVY.US trades 170.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sonova Holding AG fundamental analysis
No fundamental analysis for Sonova Holding AG yet.
Sonova Holding AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sonova Holding AG
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speec…
Full company profileSonova Holding AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Sonova Holding AG annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.40B | 2.65B | 2.76B | 2.92B | 2.60B | 3.36B | 3.74B | 3.63B | 3.87B | 3.61B | 7.36B |
| Gross Profit | 1.61B | 1.82B | 1.92B | 2.04B | 1.84B | 2.42B | 2.59B | 2.62B | 2.78B | 2.66B | 5.50B |
| Operating Income | 464M | 474M | 536M | 511M | 559M | 785M | 762M | 670M | 692M | 676M | 1.52B |
| EBITDA | 566M | 616M | 660M | 711M | 755M | 961M | 979M | 922M | 927M | 931M | 1.91B |
| Net Income | 349M | 400M | 454M | 483M | 581M | 649M | 648M | 601M | 541M | 431M | 1.01B |
| EPS | 1.06 | 1.21 | 1.38 | 1.50 | 1.84 | 2.07 | 2.14 | 2.01 | 1.81 | 1.42 | 3.39 |
| Balance Sheet | |||||||||||
| Total Assets | 3.94B | 4.30B | 4.29B | 4.49B | 5.93B | 5.59B | 5.55B | 5.79B | 5.92B | 5.63B | 5.88B |
| Total Liabilities | 1.80B | 1.83B | 1.92B | 2.46B | 3.15B | 3.16B | 3.32B | 3.30B | 3.24B | 2.99B | 3.09B |
| Shareholders' Equity | 2.11B | 2.45B | 2.35B | 2.01B | 2.75B | 2.41B | 2.21B | 2.47B | 2.66B | 2.61B | 2.77B |
| Cash & Short-term Investments | 376M | 553M | 375M | 453M | 1.77B | 612M | 415M | 514M | 687M | 722M | 672M |
| Total Debt | 780M | 759M | 610M | 1.06B | 1.83B | 1.48B | 1.81B | 1.79B | 1.76B | 1.71B | 1.74B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 520M | 523M | 533M | 843M | 764M | 941M | 784M | 753M | 794M | 708M | 1.38B |
| Capital Expenditure | 98.2M | 96.3M | 118M | 129M | 89.2M | 107M | 154M | 129M | 138M | 81.4M | 205M |
| Free Cash Flow | 422M | 426M | 415M | 715M | 675M | 835M | 630M | 625M | 656M | 626M | 1.18B |
| Ratios | |||||||||||
| ROE | 16.6% | 16.3% | 19.3% | 24.0% | 21.1% | 26.9% | 29.3% | 24.3% | 20.3% | 16.5% | 36.5% |
| ROA | 8.9% | 9.3% | 10.6% | 10.8% | 9.8% | 11.6% | 11.7% | 10.4% | 9.1% | 7.6% | 17.1% |
| Net Profit Margin | 14.6% | 15.1% | 16.4% | 16.6% | 22.3% | 19.3% | 17.3% | 16.6% | 14.0% | 11.9% | 13.7% |
| Debt to Equity | 0.37x | 0.31x | 0.26x | 0.53x | 0.67x | 0.62x | 0.82x | 0.73x | 0.66x | 0.65x | 0.63x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Sonova Holding AG dividends
- Dividend yield
- 1.69%
- Forward dividend
- 1.16 USD
- Payout ratio
- 60.9%
- Ex-dividend date
- Jun 22, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | CHF 262M | 0.87 | 60.9% |
| 2025 | CHF 256M | 0.86 | 47.4% |
| 2024 | CHF 274M | 0.92 | 45.6% |
| 2023 | CHF 268M | 0.89 | 41.3% |
| 2022 | CHF 202M | 0.64 | 31.1% |
| 2021 | CHF 200K | 0.00 | 0.0% |
| 2020 | CHF 187M | 0.58 | 38.6% |
| 2019 | CHF 170M | 0.52 | 37.4% |
| 2018 | CHF 150M | 0.46 | 37.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 151:150 on Jun 17, 2020.
Who owns Sonova Holding AG
- Insiders 0.00%
- Institutions 0.02%
- Public & others 99.99%
- Shares outstanding 298M
- Free float 297M
Sonova Holding AG company profile
- Company name
- Sonova Holding AG
- Ticker
- SONVY.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 18,837
- Fiscal year end
- March
- Address
- Laubisrütistrasse 28, Stäfa, Switzerland, 8712
- Phone
- 41 58 928 33 33
- Website
- sonova.com
About Sonova Holding AG
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing instruments and related products under the Advanced Bionics brand. The Lifestyle-Aligned segment designs connected solutions and integrating AI and digital capabilities. It sells its products directly to end consumers through its own store network; wholesales to independent audiologists, third party retail chains, and multinational and government customers; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
Sonova Holding AG management
10- Mr. Eric BernardChief Executive Officer · born 1967
- Ms. Katya KruglovaChief Human Resources Officer & Member of Management Board · born 1971
- Mr. Oliver LuxPresident of EMEA & LA Region and Member of Management Board · born 1976
- Ms. Lilika BeckPresident of Consumer Hearing & Member of Management Board · born 1979
- Mr. Alistair SimpsonMember of Management Board & Group VP of Cochlear Implants · born 1969
- Mr. Anders RosengrenChief Research & Development Officer and Member of Management Board · born 1965
- Ms. Elodie Carr-CingariChief Financial Officer · born 1974
- Mr. Roberto di FioreCOO & Member of Management Board · born 1974
- Mr. Peter DicksonSenior Director of Investor Relations
- Mr. Franz BrandChief Legal & Compliance Officer · born 1959